Asserter profile

Orbimed Royalty & Credit Opportunities III, LP

unclassified0 patents now2 ever0 cases filed during tenure1 connection

Also seen as: OrbiMed Royalty & Credit Opportunities III, LP

PTAB exposure

2of this entity’s patents have been challenged at PTAB (2 total proceedings).

Two-hop network

Edges marked ⚖️ overlap with at least one infringement suit filed during the receiving entity’s tenure with the patent. Bold-bordered = this entity. Red = NPE; orange = shell LLC; green = defensive aggregator; blue = operating company.

flowchart LR
    Norbimed_royalty_and_credit_opportunities_iii["Orbimed Royalty & Credit Opportunities…"]
    Naegis_therapeutics_and_neurelis["Aegis Therapeutics, LLC and Neurelis, I…"]
    Naegis_therapeutics_and_neurelis -->|"2021 · Security Interest · 11241414"| Norbimed_royalty_and_credit_opportunities_iii
    Norbimed_royalty_and_credit_opportunities_iii -->|"2024 · Release · 11241414"| Naegis_therapeutics_and_neurelis
    Naegis_therapeutics_and_neurelis -->|"2021 · Security Agreement · 11793786"| Norbimed_royalty_and_credit_opportunities_iii
    Norbimed_royalty_and_credit_opportunities_iii -->|"2024 · Release · 11793786"| Naegis_therapeutics_and_neurelis
    classDef focal fill:#fef3c7,stroke:#92400e,stroke-width:3px,color:#1c1917
    classDef npe fill:#fee2e2,stroke:#be123c,stroke-width:2px,color:#1c1917
    classDef shell fill:#fed7aa,stroke:#9a3412,stroke-width:2px,color:#1c1917
    classDef defensive fill:#dcfce7,stroke:#15803d,stroke-width:2px,color:#1c1917
    classDef operating fill:#e0f2fe,stroke:#075985,stroke-width:1px,color:#1c1917
    class Norbimed_royalty_and_credit_opportunities_iii focal
    class Naegis_therapeutics_and_neurelis operating

Patents previously held (2)

Connected entities (1)